ExploreOutcomewound complications and bleeding
Outcome

wound complications and bleeding

Also known as: 30-day wound complications and bleeding
3 findings 1 paper 3 related entities View in graph →

Related entities

interventions
conditions
studys

Findings (27)

None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42
None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42
None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42
None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42
None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42
None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42
None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42
None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42
None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42
None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42
None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42
None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42
None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42
None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42
None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42
None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42
None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42
None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42
None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42
None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42
None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42
None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42
None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42
None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42
None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42
None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42
None
adverse

Bypass-first revascularization was associated with significantly higher 30-day wound complication rates (9.7% vs 3.7%; adjusted OR 2.75, 95% CI 1.71-4.42) and higher blood transfusion or secondary pro

Effect: adverse; OR 2.75; CI: 95% CI 1.71-4.42

Size: OR 2.75 CI: 95% CI 1.71-4.42

Papers (1)